MTOR and cervical carcinoma: Moreover, metformin can inhibit PI3K/Akt/mTOR signal pathway expression and has been shown to have chemopreventive effects against cervical cancer and is currently being explored as a therapeutic option with both indirect (i.e., insulin-dependent) and direct (i.e., insulin-independent) mechanism of action against a variety of cancer types34.